Court Ruling Lifts DexCom

DexCom(DXCM Quote) was higher after the San Diego-based medical-device company said a U.S. District Court in Delaware granted its motion to stay the patent-infringement case brought against it by a unit of Abbott Laboratories (ABT Quote).

The court granted DexCom's motion to stay the litigation pending re-examination of the patents by the U.S. Patent and Trademark Office. The company also said the court dismissed a claim in Abbott's lawsuit where Abbott sought to add three additional patents to the litigation.

DexCom said Abbott later filed a separate action alleging patent infringement of those same three additional patents. DexCom says the complaint has no merit.

Shares of DexCom gained $1.93, or 15.8%, to $14.15.